Saturday 17 October 2026
Export CDNA’s income statement to Excel — free account
CareDx, Inc.
CDNA Healthcare Diagnostics & Research
CareDx, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $379.8 million, up 13.8% from fiscal 2024. In the quarter to June 2026, revenue grew 52.2%, EPS grew 1,443.8% and free cash flow grew 223.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
63.81
2.87
−4.30%
Follow CDNA
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 2 | 6 | 5 | 6 | 4 | 2 | 2 | 7 | 5 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.19 | 0.00 |
Altman Z-Score |
(4.71) | (3.80) | 12.88 | 7.86 | 21.89 | 14.31 | 2.88 | (0.38) | 5.83 | 4.14 |
P/S ratio |
0.93 | 3.40 | 11.70 | 7.16 | 17.52 | 8.02 | 1.84 | 2.29 | 3.39 | 2.64 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 153.61 | 0.00 | 0.00 | 0.00 | 38.08 | 29.06 |
Altman Z″-Score (non-manufacturers) |
(13.15) | (13.42) | (2.59) | (4.68) | 3.31 | 6.42 | 4.08 | (3.02) | 3.44 | (0.76) |
P/Operating CF |
(12.40) | (76.51) | 448.43 | (839.53) | 468.96 | 570.31 | 82.38 | (76.60) | 51.62 | 46.99 |
Beneish M-Score |
(3.36) | (4.85) | (2.40) | (2.10) | (2.86) | (1.91) | (2.78) | (4.44) | (2.23) | (3.36) |
P/B ratio |
1.92 | 0.00 | 9.34 | 9.18 | 12.13 | 5.10 | 1.37 | 2.46 | 2.99 | 3.31 |
Price to Tangible BV |
0.00 | 0.00 | 17.68 | 30.71 | 16.08 | 6.27 | 1.69 | 3.66 | 3.77 | 4.35 |
EV/Sales |
1.10 | 3.76 | 11.04 | 6.86 | 16.44 | 6.85 | 0.94 | 1.46 | 2.61 | 2.18 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.26 | 0.00 |
EV/Operating CF |
(2.70) | (12.70) | (210.93) | (314.74) | 94.51 | (105.21) | (11.93) | (22.24) | 22.91 | 19.73 |
EV/FCF |
(2.61) | (12.53) | (139.89) | (120.34) | 144.12 | (51.32) | (6.08) | (14.29) | 29.38 | 24.00 |
Quick Ratio |
0.49 | 0.46 | 3.81 | 1.79 | 3.75 | 5.28 | 4.73 | 3.67 | 3.64 | 2.45 |
Current Ratio |
0.65 | 0.62 | 4.16 | 2.07 | 3.95 | 5.61 | 5.11 | 4.02 | 3.94 | 2.86 |
Net Debt/EBITDA |
(0.22) | (1.35) | 7.26 | 2.20 | 17.31 | 20.85 | 4.82 | 1.25 | (4.26) | 19.49 |
Debt/Assets |
31.21% | 40.76% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
1.21 | (5.72) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.61 | 0.60 | 0.71 | 0.90 | 0.74 | 0.63 | 0.58 | 0.56 | 0.70 | 0.84 |
Operating CF/Net income |
0.42 | 0.26 | 0.09 | 0.13 | (1.79) | 0.63 | 0.33 | 0.10 | 0.72 | (1.97) |
Capex/Depreciation |
(0.08) | (0.02) | (1.08) | (0.47) | (1.09) | (1.56) | (1.48) | (0.62) | (0.32) | (0.30) |
Interest Coverage |
(20.07) | (3.46) | (4.21) | (24.91) | (83.13) | (185.79) | (20.53) | — | — | — |
| (160.26%) | (803.49%) | (103.93%) | (22.54%) | (9.94%) | (8.25%) | (17.09%) | (54.98%) | 16.43% | (6.27%) | |
| (59.64%) | (69.21%) | (43.64%) | (15.56%) | (7.19%) | (6.56%) | (13.81%) | (37.69%) | 10.97% | (4.72%) | |
ROIC |
(88.22%) | (113.15%) | (31.09%) | (25.23%) | (26.58%) | (15.83%) | (35.02%) | (490.55%) | 21.63% | (15.28%) |
Return on Tangible Assets |
351.52% | 394.40% | (71.12%) | (52.90%) | (8.72%) | (8.11%) | (22.05%) | (70.24%) | 17.75% | (10.66%) |
Average Days of Receivables |
24.87 | 22.59 | 46.53 | 69.10 | 65.76 | 73.59 | 75.22 | 66.48 | 70.65 | 40.97 |
Research and Development Expense of Revenue |
30.48% | 25.64% | 18.96% | 24.17% | 25.46% | 25.82% | 28.09% | 29.40% | 21.72% | 18.81% |
Selling, General and Administrative Expense of Revenue |
78.49% | 68.08% | 58.31% | 59.37% | 53.42% | 51.35% | 61.04% | 72.38% | 62.05% | 55.35% |
Intangible Assets out of Total Assets |
0.61 | 0.54 | 0.35 | 0.46 | 0.19 | 0.15 | 0.15 | 0.18 | 0.16 | 0.18 |
Share Based Compensation of Revenue |
4.92% | 3.61% | 9.32% | 17.64% | 12.18% | 12.17% | 14.47% | 17.51% | 19.89% | 9.18% |
Graham Net Nets |
(0.80) | (0.38) | 0.05 | 0.02 | 0.05 | 0.14 | 0.47 | 0.17 | 0.21 | 0.15 |
Graham Number |
0.00 | 3.56 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.77 | 0.00 |
Earnings Yield |
(108.65%) | (31.35%) | (5.29%) | (2.41%) | (0.58%) | (1.30%) | (12.97%) | (29.65%) | 4.72% | (2.12%) |
Free Cash Flow Yield |
(44.99%) | (8.81%) | (0.67%) | (0.80%) | 0.65% | (1.66%) | (8.38%) | (4.46%) | 2.63% | 3.44% |
Revenue per Share |
2.46 | 2.07 | 2.15 | 3.01 | 4.13 | 5.67 | 6.03 | 5.21 | 6.32 | 7.13 |
Operating CF per Share |
(1.00) | (0.61) | (0.11) | (0.07) | 0.72 | (0.37) | (0.47) | (0.34) | 0.72 | 0.79 |
Capex per Share |
(0.03) | (0.01) | (0.20) | (0.08) | (0.22) | (0.39) | (0.46) | (0.17) | (0.12) | (0.12) |
Free Cash Flow per Share |
(1.03) | (0.62) | (0.32) | (0.15) | 0.50 | (0.76) | (0.93) | (0.51) | 0.60 | 0.67 |
Cash per Share |
1.05 | 0.72 | 1.81 | 0.91 | 4.83 | 6.67 | 5.50 | 4.38 | 4.94 | 3.33 |
Shareholders Equity per Share |
1.20 | (0.26) | 2.69 | 2.35 | 5.97 | 8.92 | 8.08 | 4.86 | 7.17 | 5.69 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.20 | (0.26) | 2.69 | 2.35 | 5.97 | 8.92 | 8.08 | 4.86 | 7.17 | 5.69 |
Free Cash Flow |
(17.07) | (14.49) | (11.24) | (6.12) | 23.07 | (39.55) | (49.57) | (27.63) | 31.56 | 35.44 |
Working Capital |
(14.16) | (16.14) | 61.61 | 37.09 | 203.88 | 356.06 | 311.87 | 235.64 | 262.46 | 167.28 |
Capital Expenditures |
(0.55) | (0.19) | (7.24) | (3.35) | (10.36) | (20.26) | (24.33) | (9.24) | (6.48) | (6.59) |
Net Current Asset Value |
(30.30) | (62.75) | 46.35 | 19.19 | 182.27 | 332.62 | 275.77 | 108.22 | 239.22 | 147.01 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 21.38 | 0.00 |
Capex to Sales |
0.01 | 0.00 | 0.09 | 0.03 | 0.05 | 0.07 | 0.08 | 0.03 | 0.02 | 0.02 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 27.72 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
2.37 | 3.66 | 1.62 | 1.61 | 0.89 | 0.59 | 0.46 | 0.42 | 0.61 | 0.66 |
Cash ROIC |
(28.00%) | (32.21%) | (7.00%) | (4.46%) | 4.59% | (4.86%) | (6.85%) | (5.56%) | 4.94% | 7.38% |
Accounts Receivable Turnover |
15.83 | 16.78 | 12.01 | 7.52 | 6.55 | 6.28 | 5.10 | 4.78 | 5.77 | 7.08 |
Accounts Payable Turnover |
8.97 | 6.62 | 8.14 | 8.90 | 8.33 | 8.47 | 9.64 | 8.95 | 10.67 | 13.95 |
Inventory Turnover |
6.78 | 3.89 | 6.30 | 8.30 | 7.88 | 7.16 | 6.16 | 5.27 | 5.63 | 5.33 |
Average Days of Payables |
52.96 | 57.92 | 52.13 | 44.21 | 55.82 | 49.99 | 32.34 | 46.03 | 25.57 | 29.58 |
Days of Inventory on Hand |
94.37 | 94.43 | 54.69 | 48.29 | 57.90 | 64.41 | 62.56 | 69.63 | 64.89 | 79.09 |
Average Receivables |
2.57 | 2.88 | 6.38 | 16.91 | 29.34 | 47.19 | 63.04 | 58.69 | 57.83 | 53.62 |
Average Payables |
2.35 | 3.23 | 4.05 | 5.11 | 7.58 | 11.50 | 11.64 | 11.41 | 10.28 | 8.84 |
Average Inventory |
3.11 | 5.50 | 5.24 | 5.48 | 8.01 | 13.60 | 18.21 | 19.35 | 19.49 | 23.10 |
Average Assets |
66.18 | 80.15 | 107.13 | 141.22 | 260.12 | 467.57 | 554.81 | 504.91 | 478.94 | 452.14 |
Average Common Equity |
24.63 | 6.90 | 44.99 | 97.46 | 188.34 | 371.78 | 448.39 | 346.12 | 319.88 | 340.77 |
Columns are period end dates